Traws Pharma, Inc. (TRAW)
NASDAQ: TRAW · Real-Time Price · USD
5.02
-0.47 (-8.56%)
Dec 20, 2024, 4:00 PM EST - Market closed
Traws Pharma Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 0.23 | 0.23 | 0.23 | 0.23 | 0.23 | 2.18 | Upgrade
|
| Revenue Growth (YoY) | 0% | 0% | 0% | -2.16% | -89.42% | 77.77% | Upgrade
|
| Gross Profit | 0.23 | 0.23 | 0.23 | 0.23 | 0.23 | 2.18 | Upgrade
|
| Selling, General & Admin | 10.9 | 9.09 | 8.45 | 9.43 | 8.33 | 6.78 | Upgrade
|
| Research & Development | 13.42 | 11.43 | 11.41 | 7.3 | 16.9 | 15.26 | Upgrade
|
| Operating Expenses | 24.32 | 20.52 | 19.85 | 16.72 | 25.22 | 22.04 | Upgrade
|
| Operating Income | -24.09 | -20.3 | -19.63 | -16.5 | -24.99 | -19.86 | Upgrade
|
| Interest & Investment Income | 1.39 | 1.39 | - | - | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | -0.04 | -0.04 | - | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | -0.58 | - | 0.66 | 0.33 | -0.16 | 0.21 | Upgrade
|
| EBT Excluding Unusual Items | -23.32 | -18.95 | -18.96 | -16.16 | -25.15 | -19.65 | Upgrade
|
| Merger & Restructuring Charges | - | - | - | - | - | -1.84 | Upgrade
|
| Pretax Income | -140.79 | -18.95 | -18.96 | -16.16 | -25.15 | -21.49 | Upgrade
|
| Income Tax Expense | - | - | - | - | 0 | 0.01 | Upgrade
|
| Earnings From Continuing Operations | -140.79 | -18.95 | -18.96 | -16.16 | -25.16 | -21.5 | Upgrade
|
| Net Income | -140.79 | -18.95 | -18.96 | -16.16 | -25.16 | -21.5 | Upgrade
|
| Net Income to Common | -140.79 | -18.95 | -18.96 | -16.16 | -25.16 | -21.5 | Upgrade
|
| Shares Outstanding (Basic) | 1 | 1 | 1 | 1 | 0 | 0 | Upgrade
|
| Shares Outstanding (Diluted) | 1 | 1 | 1 | 1 | 0 | 0 | Upgrade
|
| Shares Change (YoY) | 18.39% | 0.39% | 24.22% | 45.08% | 1109.88% | 248.78% | Upgrade
|
| EPS (Basic) | -141.78 | -22.57 | -22.68 | -24.01 | -54.21 | -560.57 | Upgrade
|
| EPS (Diluted) | -141.78 | -22.57 | -22.75 | -24.01 | -54.21 | -560.57 | Upgrade
|
| Free Cash Flow | -30.18 | -17.95 | -16.29 | -19.49 | -23.09 | -20.89 | Upgrade
|
| Free Cash Flow Per Share | -30.40 | -21.38 | -19.48 | -28.94 | -49.75 | -544.49 | Upgrade
|
| Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | Upgrade
|
| Operating Margin | -10661.06% | -8981.42% | -8684.51% | -7299.12% | -10819.48% | -909.57% | Upgrade
|
| Profit Margin | -62294.25% | -8384.07% | -8391.15% | -7151.77% | -10890.48% | -985.02% | Upgrade
|
| Free Cash Flow Margin | -13354.87% | -7940.71% | -7209.73% | -8622.57% | -9995.67% | -956.76% | Upgrade
|
| EBITDA | -24.08 | -20.28 | -19.61 | -16.48 | -24.98 | -19.84 | Upgrade
|
| D&A For EBITDA | 0.01 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade
|
| EBIT | -24.09 | -20.3 | -19.63 | -16.5 | -24.99 | -19.86 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.